SCHEMBL28459047

SCHEMBL28459047

NC(=S)CC(=O)C=CC=Cc1ccc2c(c1)OCO2

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 3/20 0.65
▸ CYP1A2 P05177 2/20 0.65
▸ HDAC6 Q9UBN7 2/20 0.64
▸ GABRA1 P14867 5/20 0.59
▸ GABRB2 P47870 5/20 0.59
▸ TRPV1 Q8NER1 4/20 0.59
▸ GABRG2 P18507 2/20 0.57
▸ GABRB3 P28472 2/20 0.57
▸ GABRA3 P34903 2/20 0.57
▸ GABRA2 P47869 2/20 0.57
▸ CYP3A4 P08684 3/20 0.56
▸ MAOB P27338 2/20 0.56
▸ KDM4E B2RXH2 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ HPGD P15428 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ CTSD P07339 1/20 0.56
▸ ABCB1 P08183 1/20 0.56
▸ ALOX5 P09917 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4522260 0.92 HSD17B10 (0.76) HSD17B10CYP1A2HDAC6GABRA1GABRB2
SCHEMBL1344559 0.84 HSD17B10 (0.76) HSD17B10CYP1A2HDAC6GABRA1GABRB2
SCHEMBL11458656 0.84 HSD17B10 (0.76) HSD17B10CYP1A2HDAC6GABRA1GABRB2
SCHEMBL11441141 0.84 HSD17B10 (0.76) HSD17B10CYP1A2HDAC6GABRA1GABRB2
SCHEMBL28583726 0.84 HSD17B10 (0.76) HSD17B10CYP1A2HDAC6GABRA1GABRB2
SCHEMBL10788836 0.83 HSD17B10 (0.70) HSD17B10CYP1A2HDAC6GABRA1GABRB2
SCHEMBL17691541 0.82 MAPT (0.71) HSD17B10CYP1A2HDAC6TRPV1CYP3A4
SCHEMBL25423911 0.81 HSD17B10 (0.72) HSD17B10CYP1A2HDAC6GABRA1GABRB2
SCHEMBL7040103 0.80 HDAC6 (0.78) HSD17B10CYP1A2HDAC6GABRA1GABRB2
Piperic Acid SCHEMBL11460093 0.79 HSD17B10 (1.00) HSD17B10CYP1A2HDAC6GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105682650-B Methods and compositions for treating withdrawal syndrome using non-sedating dexmedetomidine transdermal compositions 帝国制药美国公司 2020-09-25 — — CN disclosed
Send feedback